Memphis Galleria Hometraining is a medicare approved dialysis facility center in Lakeland, Tennessee and it has 5 dialysis stations. It is located in Shelby county at 9045 Hwy 64, Lakeland, TN, 38002. You can reach out to the office of Memphis Galleria Hometraining at (901) 213-2955. This dialysis clinic is managed and/or owned by Davita. Memphis Galleria Hometraining has the following ownership type - Profit. It was first certified by medicare in November, 2008. The medicare id for this facility is 442678 and it accepts patients under medicare ESRD program.
Name | Memphis Galleria Hometraining |
---|---|
Location | 9045 Hwy 64, Lakeland, Tennessee |
No. of Dialysis Stations | 5 |
Medicare ID | 442678 |
Managed By | Davita |
Ownership Type | Profit |
Late Shifts | No |
9045 Hwy 64, Lakeland, Tennessee, 38002 | |
(901) 213-2955 | |
Not Available |
News Archive
A lack of sunlight is associated with reduced cognitive function among depressed people. Researchers writing in BioMed Central's open access journal Environmental Health used weather data from NASA satellites to measure sunlight exposure across the United States and linked this information to the prevalence of cognitive impairment in depressed people.
A new diagnostic tool is expected to result in better treatment of cancer that is difficult to diagnose. The tool was developed by cancer researchers at Sahlgrenska Academy and doctors at the Sahlgrenska University Hospital, Sweden. Their study, which has been published in JCO Precision Oncology, started with a single cancer patient.
At the Alzheimer's Association International Conference 2015 in Washington D.C., MetLife Foundation presented its annual MetLife Foundation Awards for Medical Research. These awards were presented to Randall Bateman, M.D., and Christian Haass, Ph.D., for their contributions in advancing Alzheimer's disease research.
A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor, reports a multi-institutional team led by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego.
› Verified 4 days ago
NPI Number | 1053599357 |
Organization Name | Galleria Home Training Dialysis |
Doing Business As | Somerville Dialysis Center Llc |
Address | 9045 Highway 64 Lakeland, Tennessee, 38002 |
Phone Number | (901) 213-2955 |
News Archive
A lack of sunlight is associated with reduced cognitive function among depressed people. Researchers writing in BioMed Central's open access journal Environmental Health used weather data from NASA satellites to measure sunlight exposure across the United States and linked this information to the prevalence of cognitive impairment in depressed people.
A new diagnostic tool is expected to result in better treatment of cancer that is difficult to diagnose. The tool was developed by cancer researchers at Sahlgrenska Academy and doctors at the Sahlgrenska University Hospital, Sweden. Their study, which has been published in JCO Precision Oncology, started with a single cancer patient.
At the Alzheimer's Association International Conference 2015 in Washington D.C., MetLife Foundation presented its annual MetLife Foundation Awards for Medical Research. These awards were presented to Randall Bateman, M.D., and Christian Haass, Ph.D., for their contributions in advancing Alzheimer's disease research.
A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor, reports a multi-institutional team led by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego.
› Verified 4 days ago
Dialysis patients with Hemoglobin data | 23 |
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 4 |
News Archive
A lack of sunlight is associated with reduced cognitive function among depressed people. Researchers writing in BioMed Central's open access journal Environmental Health used weather data from NASA satellites to measure sunlight exposure across the United States and linked this information to the prevalence of cognitive impairment in depressed people.
A new diagnostic tool is expected to result in better treatment of cancer that is difficult to diagnose. The tool was developed by cancer researchers at Sahlgrenska Academy and doctors at the Sahlgrenska University Hospital, Sweden. Their study, which has been published in JCO Precision Oncology, started with a single cancer patient.
At the Alzheimer's Association International Conference 2015 in Washington D.C., MetLife Foundation presented its annual MetLife Foundation Awards for Medical Research. These awards were presented to Randall Bateman, M.D., and Christian Haass, Ph.D., for their contributions in advancing Alzheimer's disease research.
A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor, reports a multi-institutional team led by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego.
› Verified 4 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
Adult patients getting regular peritoneal dialysis at the center | 53 |
Adult patient months included in Kt/V greater than or equal to 1.7 | 438 |
Percentage of adult patients getting regular peritoneal dialysis at the center | 99 |
Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
A lack of sunlight is associated with reduced cognitive function among depressed people. Researchers writing in BioMed Central's open access journal Environmental Health used weather data from NASA satellites to measure sunlight exposure across the United States and linked this information to the prevalence of cognitive impairment in depressed people.
A new diagnostic tool is expected to result in better treatment of cancer that is difficult to diagnose. The tool was developed by cancer researchers at Sahlgrenska Academy and doctors at the Sahlgrenska University Hospital, Sweden. Their study, which has been published in JCO Precision Oncology, started with a single cancer patient.
At the Alzheimer's Association International Conference 2015 in Washington D.C., MetLife Foundation presented its annual MetLife Foundation Awards for Medical Research. These awards were presented to Randall Bateman, M.D., and Christian Haass, Ph.D., for their contributions in advancing Alzheimer's disease research.
A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor, reports a multi-institutional team led by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego.
› Verified 4 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Memphis Galleria Hometraining with elevated calcium levels.
Patients with hypercalcemia | 58 |
Hypercalcemia patient months | 486 |
Patients with Serumphosphor | 59 |
Patients with Serumphosphor less than 3.5 mg/dL | 7 |
Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 24 |
Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 30 |
Patients with Serumphosphor from 5.6 to 7 mg/dL | 23 |
Patients with Serumphosphor greater than 7 mg/dL | 16 |
News Archive
A lack of sunlight is associated with reduced cognitive function among depressed people. Researchers writing in BioMed Central's open access journal Environmental Health used weather data from NASA satellites to measure sunlight exposure across the United States and linked this information to the prevalence of cognitive impairment in depressed people.
A new diagnostic tool is expected to result in better treatment of cancer that is difficult to diagnose. The tool was developed by cancer researchers at Sahlgrenska Academy and doctors at the Sahlgrenska University Hospital, Sweden. Their study, which has been published in JCO Precision Oncology, started with a single cancer patient.
At the Alzheimer's Association International Conference 2015 in Washington D.C., MetLife Foundation presented its annual MetLife Foundation Awards for Medical Research. These awards were presented to Randall Bateman, M.D., and Christian Haass, Ph.D., for their contributions in advancing Alzheimer's disease research.
A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor, reports a multi-institutional team led by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego.
› Verified 4 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
Patients included in arterial venous fistula and catheter summaries | 5 |
Patient months included in arterial venous fistula and catheter summaries | 42 |
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | |
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer |
News Archive
A lack of sunlight is associated with reduced cognitive function among depressed people. Researchers writing in BioMed Central's open access journal Environmental Health used weather data from NASA satellites to measure sunlight exposure across the United States and linked this information to the prevalence of cognitive impairment in depressed people.
A new diagnostic tool is expected to result in better treatment of cancer that is difficult to diagnose. The tool was developed by cancer researchers at Sahlgrenska Academy and doctors at the Sahlgrenska University Hospital, Sweden. Their study, which has been published in JCO Precision Oncology, started with a single cancer patient.
At the Alzheimer's Association International Conference 2015 in Washington D.C., MetLife Foundation presented its annual MetLife Foundation Awards for Medical Research. These awards were presented to Randall Bateman, M.D., and Christian Haass, Ph.D., for their contributions in advancing Alzheimer's disease research.
A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor, reports a multi-institutional team led by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego.
› Verified 4 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
Patients in facility's Hospitalization Summary | 35 |
Hospitalization Rate in facility | 170.8 (As Expected) |
Hospitalization Rate: Upper Confidence Limit | 338 |
Hospitalization Rate: Lower Confidence Limit | 91.1 |
News Archive
A lack of sunlight is associated with reduced cognitive function among depressed people. Researchers writing in BioMed Central's open access journal Environmental Health used weather data from NASA satellites to measure sunlight exposure across the United States and linked this information to the prevalence of cognitive impairment in depressed people.
A new diagnostic tool is expected to result in better treatment of cancer that is difficult to diagnose. The tool was developed by cancer researchers at Sahlgrenska Academy and doctors at the Sahlgrenska University Hospital, Sweden. Their study, which has been published in JCO Precision Oncology, started with a single cancer patient.
At the Alzheimer's Association International Conference 2015 in Washington D.C., MetLife Foundation presented its annual MetLife Foundation Awards for Medical Research. These awards were presented to Randall Bateman, M.D., and Christian Haass, Ph.D., for their contributions in advancing Alzheimer's disease research.
A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor, reports a multi-institutional team led by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego.
› Verified 4 days ago
The rate of readmission show you whether patients who were being treated regularly at Memphis Galleria Hometraining were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
Readmission Rate in facility | 30.8 (As Expected) |
Readmission Rate: Upper Confidence Limit | 49.6 |
Readmission Rate: Lower Confidence Limit | 16.6 |
News Archive
A lack of sunlight is associated with reduced cognitive function among depressed people. Researchers writing in BioMed Central's open access journal Environmental Health used weather data from NASA satellites to measure sunlight exposure across the United States and linked this information to the prevalence of cognitive impairment in depressed people.
A new diagnostic tool is expected to result in better treatment of cancer that is difficult to diagnose. The tool was developed by cancer researchers at Sahlgrenska Academy and doctors at the Sahlgrenska University Hospital, Sweden. Their study, which has been published in JCO Precision Oncology, started with a single cancer patient.
At the Alzheimer's Association International Conference 2015 in Washington D.C., MetLife Foundation presented its annual MetLife Foundation Awards for Medical Research. These awards were presented to Randall Bateman, M.D., and Christian Haass, Ph.D., for their contributions in advancing Alzheimer's disease research.
A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor, reports a multi-institutional team led by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego.
› Verified 4 days ago